Children with mild asthma and normal pulmonary function can still be considered candidates for early inhaled corticosteroids use, Dutch clinicians suggest.
Pulmonary specialists at the Wilhelmina Children’s Hospital, University Medical Centre, Utrecht, the Netherlands, point out that objective measurement of the effect of inhaled corticosteroids is difficult among such children.
This prompted their study of the short term effect of fluticasone propionate (FP) in such a population. A cohort of 68 children between the ages of 5 and 10 years old received either FP 250 micrograms, or placebo, twice daily as metered-dose inhaler via spacer over 12 weeks. Clinicians used both objective and subjective scoring, including use of rescue medication, wheezing, and parent global evaluation.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!